LabCorp (NYSE: LH), an S&P 500 company, is a leading global life sciences company that is deeply integrated in guiding patient care, providing comprehensive clinical laboratory and end-to-end drug development services. With a mission to improve health and improve lives, LabCorp delivers world-class diagnostic solutions, brings innovative medicines to patients faster and uses technology to improve the delivery of care. LabCorp reported net revenues of over $10 billion in ...Read More >>
There are currently no events scheduled.
The National Football League Alumni, Cancer Treatment Centers of America®, LabCorp® and Health Testing Centers Team Up to Offer Prostate Cancer Screenings in September
LabCorp Announces 2018 Second Quarter Results and Updates 2018 Guidance
Robert E. Mittelstaedt, Jr. to Retire from LabCorp Board of Directors and Current Board Member Adam H. Schechter to Assume Role of Lead Independent Director in 2019
|Print Page | E-mail Page | RSS Feeds | E-mail Alerts | IR Contacts | Tear Sheet|